Marine Natural Products: A Source of Novel Anticancer Drugs
Open accessThe DOI matches its Crossref record; 215 of the 235 references it cites were found in a registry or an index; 37 of the 152 sources its claims cite were checked for support.
Abstract
Cancer remains one of the most lethal diseases worldwide. There is an urgent need for new drugs with novel modes of action and thus considerable research has been conducted for new anticancer drugs from natural sources, especially plants, microbes and marine organisms. Marine populations represent reservoirs of novel bioactive metabolites with diverse groups of chemical structures. This review highlights the impact of marine organisms, with particular emphasis on marine plants, algae, bacteria, actinomycetes, fungi, sponges and soft corals. Anti-cancer effects of marine natural products in in vitro and in vivo studies were first introduced; their activity in the prevention of tumor formation and the related compound-induced apoptosis and cytotoxicities were tackled. The possible molecular mechanisms behind the biological effects are also presented. The review highlights the diversity of marine organisms, novel chemical structures, and chemical property space. Finally, therapeutic strategies and the present use of marine-derived components, its future direction and limitations are discussed.
Overview
CoChat Summary
TL;DR
This review summarizes marine natural products as sources of novel anticancer drugs, covering marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals. It highlights cytotoxic and mechanistic findings, clinical candidates, and chemical property-space diversity, while noting that many marine compounds remain preclinical and the deep sea is largely unexplored.
Key findings
- Marine-derived compounds show anticancer activity across many tumor cell lines: cryptophycin 1 had IC50 = 0.005 and 0.003 ng/mL against KB and LOVO cells; coibamide A had LC50 < 23 nM against NCIH460 lung and mouse neuro-2a cells; salinosporamide A had IC50 = 0.13, 0.28, 7.5, and 35.0 µM against A-549, HL-60, BEL-7402, and P388 cells, respectively.
- The review reports 13 natural products isolated from marine organisms being tested in different phases of clinical trials; examples include bryostatin 1 in phase II, ET-743 in phase I, and dolastatin 10 in phase II. Marine-based drugs cited as used against leukemia, metastatic breast cancer, soft tissue sarcoma, and ovarian cancer include cytarabine, eribulin mesylate, brentuximab vedotin, and trabectidine.
- Marine biodiversity is described as vast: oceans cover over 70% of the earth, nearly 250,000 marine species are described, 99% of all bacteria cannot be cultured, and there are more than 22,000 known microbial secondary metabolites, 70% produced by actinomycetes, 20% by fungi, 7% by Bacillus spp., and 1–2% by other bacteria.
- ChemGPS-NP analysis using eight principal components based on 35 molecular descriptors showed that the reviewed marine compounds did not form tight clusters, indicating chemical diversity within classes such as marine peptides.
Methods
- Narrative review of marine natural products with anticancer activity, emphasizing marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals, and covering in vitro, in vivo, and clinical trial reports.
- For chemical property space, chemical structures were converted to SMILES using Chemsketch and submitted to ChemGPS-NPweb; eight principal component values were obtained from 35 molecular descriptors per compound, and PC1, PC2, and PC3 were plotted in three dimensions.
- Main analysis is qualitative synthesis of reported cytotoxic activities, mechanisms, and clinical status; no systematic search strategy, inclusion criteria, or quantitative meta-analysis is described.
Limitations
- Stated in the paper: sampling difficulties and the need for sufficiently large quantities for detailed analyses; less than 5% of the deep sea has been explored and less than 0.01% of the deep-sea floor sampled in detail; preclinical and clinical data for marine natural compound chemoprevention remain scant; NMR is less sensitive than MS and some compound classes cannot be detected by MS; many compounds such as calothrixins A/B, ulithiacyclamide, patellamide, borophycin, and largazole have not yet entered clinical trials; the exact mechanism of sansalvamide A is unknown.
- Evident from the text: as a narrative review, it lacks a systematic search strategy, formal inclusion/exclusion criteria, risk-of-bias assessment, and quantitative pooling, so the findings are illustrative rather than exhaustive.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
32 Valid · 3 Not valid · 64 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Advanced technology and extensive research on marine natural products have led to the discovery of a new generation of anticancer drugs currently used in clinical trials [6].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 1. Introduction
What the sources say
- Partly supportedcites [6] Ang, 2000, In vivo antimalarial activity of the beta-carboline alkaloid manzamine A, Antimicrob. Agents Chemother. sourceExperimental — accuracy not yet measured
The Abstract (page not specified) says marine-sponge manzamines had attracted interest as potential anticancer agents and inhibited cancer-cell growth. It does not say that advanced technology produced a new generation of anticancer drugs or that any were in clinical trials; this paper reports antimalarial testing in mice. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Natural bioactive molecules exhibit cytotoxic effects by attacking macromolecules expressed by cancer cells, such as those in oncogenic signal transduction pathways [16].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 1. Introduction
What the sources say
- Supportedcites [16] Nobili, 2009, Natural compounds for cancer treatment and prevention, Pharmacol. Res. source
The Conclusions describe natural compounds with cytotoxic activity that target macromolecules in cancer cells, including compounds targeting oncogenic signal-transduction pathways. The citing sentence paraphrases that distinction. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Over the past 50 years, emerging evidence has shown that many natural products derived from plants and microbes of marine origin (Table 1), exhibit beneficial effects in the prevention and treatment of cancer, i.e., cytarabine, eribulin mesylate, brentuximab vedotin, and trabectidine are marine-based drugs used against leukemia, metastatic breast cancer, soft tissue sarcoma and ovarian cancer [20,”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 2. Nature and Cancer Chemotherapy
What the sources say
- Partly supportedcites [20] Dyshlovoy, S.A., and Honecker, F. (2018). Marine compounds and cancer: 2017 updates. Mar. Drugs, 16. sourceExperimental — accuracy not yet measured
The paper’s main text reports anticancer activity in compounds from marine algae and microbes and identifies four marine-derived drugs approved to treat cancer. It does not establish beneficial effects in cancer prevention, so the prevention portion of the claim is unsupported. (LLM, conf=0.85)
- Not matchedcites [21] (2019, August 17). Drug Bank. Available online: http://www.drugbank.ca.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The bryostatin 1 has recently entered phase II clinical trial against melanoma, non-Hodgkin’s lymphoma, renal cancer and colorectal cancer [58,59,60].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs
What the sources say
- Not checked — no full text of the sourcecites [58] Bourhill, 2017, Enzastaurin: A lesson in drug development, Crit. Rev. Oncol. Hematol. source
- Partly supportedcites [59] Wang, 2013, Marine-derived angiogenesis inhibitors for cancer therapy, Mar. Drugs sourceExperimental — accuracy not yet measured
Section 4.1 reports phase I and II bryostatin-1 trials involving all four named cancers, and the References list phase II studies for each, including colorectal cancer (ref. 132). But the paper says more than 80 phase I and II trials had been conducted since 1993; it does not support the claim that bryostatin-1 had recently entered phase II trials. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [60] Ritchie, 2015, Cancer research UK centre for drug development: Translating 21st-century science into the cancer medicines of tomorrow, Drug Discov. Today source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Based on modern research, cultured benthic cyanobacteria from temperate marine environments provide a promising, under-exploited source for novel drugs against leukemia [107].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
What the sources say
- Could not verifycites [107] Peng, 2010, Structure and absolute configuration of karlotoxin-2, an ichthyotoxin from the marine dinoflagellate Karlodinium veneficum, J. Am. Chem. Soc. sourceExperimental — accuracy not yet measured
The Abstract describes karlotoxin-2 from the marine dinoflagellate Karlodinium veneficum and its toxicity to fish. Searches for benthic cyanobacteria and leukemia found no passage addressing their potential as a source of leukemia drugs. (LLM, conf=0.77)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Could not verify
69 more claims · 15 with their cited sources checked
Create a free account to see all 110 claims and to verify the 12 references still open.
- It may state two separate claims as one. 23
- Probably not a substantial claim. 18
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
“against KB cells and 5 µg/mL against LOVO cells (colon cancer)”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
“against human epidermoid carcinoma (LOVO) and human colorectal adenocarcinoma (KB) cell lines”
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 2×
“In 2018, approximately 18 million new cases of cancer reported globally, resulting in approximately 10 million deaths [1].”
BackgroundCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Prokaryotes: The unseen majority
Whitman, W. B., Coleman, D. C., & Wiebe, W. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6578 · Cited by 4,871
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687 · cited 2×
“Approximately 80% of the approved chemotherapeutic drugs [13], and more than half of all drugs are based on bioactive natural products [14].”
BackgroundBioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170 · cited 1×
“Of these actinomycete-derived compounds, 75% were derived from Streptomyce whereas 25% were derived from rare actinomycetes [125,126].”
BackgroundNatural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082 · cited 1×
“Approximately 80% of the approved chemotherapeutic drugs [13], and more than half of all drugs are based on bioactive natural products [14].”
BackgroundMedicinal plants: Traditions of yesterday and drugs of tomorrow
Gurib-Fakim, A. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.008 · Cited by 2,391 · cited 1×
“The incidence of cancer continues to increase due to environmental changes and life style modernization [3].”
BackgroundShahidi, F., Janitha, P. K., & Wanasundara, P. D. (1992) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399209527581 · Cited by 2,238
Research works printed but not linked: 7
- Whitman, 1998, The unseen majority, Proc. Natl. Acad. Sci. USA, 74, 5088
- Reyes, 2002, The marine pharmacy: New antitumoral compounds from the sea, Pharm. News, 9, 495
- Laatsch, H. (2011). AntiBase 2011: The Natural Compound Identifier, Wiley-Vch.
- Harmon, 2000, Ecteinascidin-743 (et-743) induces objective responses and disease control in patients with advanced non-osseous sarcomas: Results from phase Ii trials, Ann. Oncol., 11, 126
- Lavakumar, 2012, Anticancer and antioxidant effect of Acanthophora spicifera against EAC induced carcinoma in mice, J. Pharm. Res., 5, 1503
- Suja, 2014, Anticancer activity of compounds isolated from marine endophytic fungus Aspergillus terreus, World J. Pharm. Pharm. Sci., 3, 661
- Devi, 2015, Molecular modeling, quantitative structure activity relationship and pharmacophore studies on antiǧviral, antiǧmalarial and antiǧinflammatory bioactive compounds from marine sources, Asian J. Pharm. Clin. Res., 8, 36
Cited by
Items 401–500 of 551
Hamai-Amara, H., Da'as, S. I., Hasan, W., Dalloul, A., Abuarja, T., Soubra, L., Dermime, S., & Saadaoui, I. (2026) · Algal Research · doi:10.1016/j.algal.2026.104668 · Cited by 2
Liu, L.-L., Sun, J., Xu, Y., He, L., Chandramouli, K., & Qian, P. (2020) · Frontiers in Marine Science · doi:10.3389/fmars.2020.00228 · Cited by 3
UHPLC-MS/MS Studies and Antiproliferative Effects in Breast Cancer Cells of Mexican Sargassum
Correa‐Basurto, J., Jonathan, F.-V. M., Darling, D., et al. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220412125740 · Cited by 2
Kanoujia, J., Das, A., Raina, N., Kaur, G., Singh, S. K., Tuli, H. S., Garg, A., & Gupta, M. (2023) · IUBMB Life · doi:10.1002/iub.2764 · Cited by 2
“For a considerable amount of time, researchers helped to trawl the seas and oceans in search of marine species with synthetic mixes that could have beneficial clinical and therapeutic benefits.(6) These add to a wide range of aquatic life, such as different mollusks, delicate tunicates, sturdy seaweeds, etc.”
BackgroundNunes, P. I. G., Viana, A. F. S. C., Sasahara, G. L., dos Santos, S. M., Alves, A. P. N. N., Silveira, E. R., & Santos, F. A. (2023) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202320220919 · Cited by 2
Emerging Potential of Momordica’s Bioactive Phytochemicals in Cancer Prevention and Therapy
Sur, S., & Ray, R. B. (2023) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2767 · Cited by 4
Manivannan, H. P., Veeraraghavan, V. P., & Francis, A. P. (2024) · Current Computer - Aided Drug Design · doi:10.2174/0115734099287118240102112337 · Cited by 2
Евгеньевна, Ф. С., Kushnerova, N. F., & Sprygin, V. G. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s002209302401006x · Cited by 2
al., M. H. A. E. (2024) · Egyptian Journal of Aquatic Biology and Fisheries · doi:10.21608/ejabf.2024.346200 · Cited by 2
El-Said, K. S., & El-Feki, S. M. (2024) · Biological and Biomedical Journal · doi:10.21608/bbj.2024.263771.1030 · Cited by 2
“A new generation of anticancer medications is presently being employed in clinical trials because of advanced technology and substantial study on marine natural ingredients (Khalifa et al., 2019).”
BackgroundNutraceuticals and Functional Foods from Algae: Formulation and Health Benefits
Manoharan, D., Thirumalaivasan, R., Sivakumar, N., Ramkumar, T., & Ponmurugan, K. (2024) · Springer eBooks · doi:10.1007/978-981-97-1662-3_13 · Cited by 5
van der Westhuyzen, A. E., Ashraf, N., Conradie, D., Loots, L., Kaschula, C. H., Pelly, S. C., Frolova, L. V., Landfair, T., Shuster, C. B., Betancourt, T., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02473 · Cited by 2
Fadil, S. A., Aljoud, F., Yonbawi, A. R., Almalki, A. J., Hareeri, R. H., Ashi, A., AlQriqri, M. A., Bawazir, N., Alshangiti, H. H., Shaala, L. A., et al. (2024) · OncoTargets and Therapy · doi:10.2147/ott.s467083 · Cited by 2
Xu, Y., Wang, Q., Xu, G., Xu, Y., & Mou, Y. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1482758 · Cited by 2
Marine-Derived Alternariol Suppresses Inflammation by Regulating T Cell Activation and Migration
Liu, C., Gu, F., Zou, Z., Wang, F., Li, D., Song, J. K., Hong, Y., Wu, X., Yang, X., Liu, W., et al. (2025) · Marine Drugs · doi:10.3390/md23030133 · Cited by 5
“In contrast to the land resources that have been widely used, marine ecosystems represent a largely unexplored source of bioactive compounds with unique structural diversity and therapeutic potential [15,16].”
Osorio-Ramírez, M. D. C., Hernández-Melgar, A. G., Cembella, A. D., Maskrey, B. H., Díaz-Rubio, L., Córdova‐Guerrero, I., Bernáldez-Sarabia, J., González‐Maya, L., Esquivel, B., Bustos‐Brito, C., et al. (2025) · Toxins · doi:10.3390/toxins17040150 · Cited by 3
“Natural products from dinoflagellates have received particular attention over the past few decades because they comprise unusual and unique derivatives of many structural classes, including numerous metabolites with promising biological activity as therapeutics [3].”
REVISÃO INTEGRATIVA SOBRE ATIVIDADE ANTITUMORAL DE MICROALGAS E CIANOBACTÉRIAS
Bezerra, R. P., de Arruda, M. C. S., Calaça, P. R. D. A., Cavalcanti, V. L. R., Brandão, R., & Porto, A. L. F. (2021) · Revista Valore · doi:10.22408/reva602021554e-6001 · Cited by 3
Jumardi, J., Arfah, R. A., & Permatasari, N. U. (2023) · Kemija u industriji · doi:10.15255/kui.2022.032 · Cited by 2
First Total Synthesis of 27-Deoxylyngbyabellin A
Liu, Y., Du, Y., & Zhang, Y. (2021) · Synthesis · doi:10.1055/a-1478-9088 · Cited by 2
Liu, X., Xu, R., Wang, L., et al. (2021) · Chinese Journal of Organic Chemistry · doi:10.6023/cjoc202101014 · Cited by 2
Bioactivity of Metabolites from Actinomycetes Isolates from Red Sea, Egypt
Osman, M., El-Nasr, A. A., Hussein, H. M., & Hamed, M. M. (2022) · Microbiology and Biotechnology Letters · doi:10.48022/mbl.2202.02003 · Cited by 3
Li, Y., Murakami, M., Huang, Y.-H., Hung, T., Wang, S.-P., Wu, Y., Ambudkar, S. V., & Wu, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112763 · Cited by 3
Ramachandran, K., Sukumaran, M., & Velavan, S. (2022) · International Journal of Zoological Investigations · doi:10.33745/ijzi.2022.v08i0s.014 · Cited by 2
Hioki, Y., Sato, T., Iwao, T., Ikuma, J., Kawamura, A., Ohyoshi, T., Tsunematsu, Y., & Kita, M. (2023) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202300084 · Cited by 2
Drug from Marine Sampling to Factory
El‐Nashar, H. A. S., Kocaeli, S., Abdallah, M., & El‐Shazly, M. (2023) · Marine ecology · doi:10.2174/9789815051995123030013 · Cited by 2
Isolation, identification and biochemical studies of gallic acid from Turbinaria decurrens Bory
Sami, F. J., & Nur, S. (2022) · Current Research on Biosciences and Biotechnology · doi:10.5614/crbb.2022.4.1/x7dd09ry · Cited by 1
Marine-Derived Materials for the Development of Advanced Drug Delivery Systems
Eğe, H., Eğe, Z. R., & Gündüz, O. (2024) · Springer eBooks · doi:10.1007/978-3-030-92090-6_55-1 · Cited by 1
Baghban, A., Rezaee, S. A., Tafaghodi, M., Bozorgmehr, M. R., & Heravi, M. M. (2024) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2024.100036 · Cited by 1
Plant-based seafoods: a sustainable and nutritious alternative
Karimidastjerd, A., Gulsunoglu‐Konuskan, Z., Ersoy, B., & Khan, Z. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16017-2.00015-2 · Cited by 1
Identification of Microorganisms Associated with Sea Cucumbers in Johor Coastal Seawater
Solehin, S. N., Kamarudin, K. R., Badrulhisham, N. S., & Rehan, A. M. (2024) · Pertanika journal of tropical agricultural science · doi:10.47836/pjtas.47.4.17 · Cited by 1
Microalgae genetic engineering for enhanced high-value bioproducts for biomedical applications
Ahmad, A., Amin, K. A., & Ashraf, S. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24006-5.00018-3 · Cited by 3
An Overview on Anticancer Drug extracted from Marine Sources
Zanjurne, N. R., Devade, O. A., Purane, L. M., & Redasani, V. (2024) · Research Journal of Pharmacology and Pharmacodynamics · doi:10.52711/2321-5836.2024.00053 · Cited by 2
Perumal, P., Arthanari, U., & Sanniyasi, E. (2025) · Chemical Papers · doi:10.1007/s11696-025-04013-8 · Cited by 1
“Marine natural products including microalgae, sea-weeds, seagrasses, mangroves, microflora, sponges and soft corals are a rich source of bioactive metabolites (Khalifa et al. 2019).”
Pang, J., Yu, Q., Wei, H., Xia, X., Lin, Z., Du, X., & Wang, C. (2025) · BMC Chemistry · doi:10.1186/s13065-025-01499-x · Cited by 1
“Upon comparing compounds 8 , 9 , 10 , and 11 , it was observed that compound 8 , featuring a nitrogen atom connected to a hydroxyethyl group, exhibited superior stability and activity compared to the other three compounds.”
Kavaliauskas, P., Acevedo, W., Mickevičiūtė, E., et al. (2025) · Pathogens · doi:10.3390/pathogens14050484 · Cited by 1
“The amide fragment in compounds 19 – 22 (Scheme 2) caused the formation of rotamers because of the restricted rotation around the CO-NH bond and was able to take part in the intermolecular and intramolecular interactions.”
InfluentialZhou, R., Lee, E.-Y., Hillman, P. F., Nam, S., & Kim, H. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00133 · Cited by 1
Chen, H., Shen, S., Wang, S.-L., Li, Y., Li, J., Cao, W.-L., Hou, Z., Jia, J.-H., Liu, Q., Yao, G., et al. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111814 · Cited by 1
Ahamed, J. M., Dayalan, S., Dahms, H.-U., et al. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214593 · Cited by 1
Isolation and cultivation of novel microorganisms for drug prospecting
Kumar, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33032-2.00012-5 · Cited by 1
Mucignat, G., Lakhdar, F., Maghrebi, H., Dejnaka, E., Lucatello, L., Benhniya, B., Capolongo, F., Etahiri, S., Pauletto, M., Pawlak, A., et al. (2025) · Marine Drugs · doi:10.3390/md23120457 · Cited by 1
Marine-Derived Anticancer Agents: Synergizing Omics and Biotechnology for Breakthroughs
RAHMAN, M. W., & Hossain, M. N. (2026) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-3612-2_15 · Cited by 2
Yıldırım, A. S., Bezir, K., Kızılkaya, İ. T., et al. (2026) · Osmaniye Korkut Ata Üniversitesi Fen Bilimleri Enstitüsü Dergisi · doi:10.47495/okufbed.1681820 · Cited by 1
Gomez, M. C., Rajendran, K., & Tayo, L. L. (2026) · Scientific Reports · doi:10.1038/s41598-026-44280-3 · Cited by 2
“Other functional groups (such as amides, amines, carboxyls, imines, sulfides, and thiols) further contribute to bioactivity and chemical versatility, providing diverse pharmacological functions and synthetic handles for modification and optimization in drug development pipelines 53 .”
Ziada, M., Mona, M., Basyony, M., & Salem, M. L. (2021) · International Journal of Cancer and Biomedical Research · doi:10.21608/jcbr.2021.54156.1105 · Cited by 1
“Natural products extracted from terrestrial and marine animals are currently in clinical trials as new drug candidates (Newman and cragg, 2004; Khalifa et al., 2019).”
BackgroundSpatial Identification of Vulnerable Coastal Ecosystems for Emerging Pollutants
Kumari, A. R., Harshawardhan, R., Kushawaha, J., & Nandi, I. (2021) · Coastal research library · doi:10.1007/978-3-030-84255-0_15 · Cited by 3
Seydi, E., Jafarzadeh, N., Naserzadeh, P., et al. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.2.511 · Cited by 1
A Comprehensive Review on the Role of Chemotype Marine Derived-Drug Discovery
Rajakumar, S., Ramprasadh, S. V., Dinesh, S., & Sharma, S. (2023) · Current Bioactive Compounds · doi:10.2174/1573407219666230622153941 · Cited by 2
Blue economic potency of marine invertebrates for bio-drug discovery
Ibrahim, H. A. H., Abd-Elnaby, H. M., Abouelkheir, S. S., Abo-Taleb, H. A. H., & El‐Sersy, N. A. (2023) · Blue Economy · doi:10.57241/2805-2986.1008 · Cited by 4
Ismail, A., Elissawy, A. M., Gad, H. A., et al. (2024) · Archives of Pharmaceutical Sciences Ain Shams University · doi:10.21608/aps.2024.264592.1156 · Cited by 1
Microbial metabolites with anticancerous properties
Kurup, N., Patil, S., Rajnani, N., & Gandhi, R. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18568-7.00008-2 · Cited by 3
Natural Compound Toxicity: An Egregiously Overlooked Topic
Bhardwaj, P., Aiman, A., Iram, F., Saifi, I., Basir, S. F., Hassan, M. I., Islam, A., & Manzoor, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_25 · Cited by 2
Asuku, A. O. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-5878-8.ch003 · Cited by 1
Bajhal, S., Boopathi, S., Arockiaraj, J., et al. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402717 · Cited by 1
Arokiarajan, M. S., Thirunavukkarasu, R., Srinivasan, N., Francis, M., Selvaraj, B., Al‐Sadoon, M. K., & Subramanian, K. (2025) · Starch - Stärke · doi:10.1002/star.70011 · Cited by 3
Aaptamine Alters Vimentin Expression and Migration Capability of Triple-Negative Breast Cancer Cells
Khairani, A. F., Shalannandia, W. A., Bashari, M. H., et al. (2025) · Journal of Experimental Pharmacology · doi:10.2147/jep.s512099 · Cited by 1
Anticancer Activity of Roburic Acid: In Vitro and In Silico Investigation
Gielecińska, A., Kciuk, M., Mujwar, S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136420 · Cited by 1
Ray, S., Banerjee, A., Paul, D., Paul, S., Debnath, B., & Das, S. (2025) · Next research. · doi:10.1016/j.nexres.2025.100627 · Cited by 2
Application of Marine-Based Gold Nanomaterials in Cancer Therapy: A Mini-ReviewPreprint
Baghban, N., Khoradmehr, A., Nabipour, I., & Tamadon, A. (2021) · Preprints.org · doi:10.20944/preprints202103.0771.v1 · Cited by 1
“The results of scientific studies on medicinal properties of these products are promising for the treating many diseases, including cancer, and are able to reduce the toxicity of other drugs due to their antioxidant properties [35].”
BackgroundDmitrenok, P. S. (2021) · Molecules · doi:10.3390/molecules26164971 · Cited by 1
“In recent years, studies of the anticancer activity of marine natural compounds have become increasingly important [1,8,9].”
BackgroundHeteronemin Promotes Iron-Dependent Cell Death in Pancreatic CancerPreprint
Kaftan, G., Erdoğan, M. A., El‐Shazly, M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1514908/v1 · Cited by 1
Sinularin stabilizes FOXO3 protein to trigger prostate cancer cell intrinsic apoptosisPreprint
Meng, X., Wang, K., Ye, S., Chen, J., Chen, Z.-Y., Zhang, Z., Li, Y., Yu, R., & Ma, Q. (2022) · Research Square · doi:10.21203/rs.3.rs-2091932/v1 · Cited by 1
dos Santos, G. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2022.tde-20072023-113231 · Cited by 3
Xu, Y., Wang, Q., Xu, G., Xu, Y., & Mou, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4163089/v1 · Cited by 1
Marine Natural Products: A Promising Frontier in Drug Discovery
Kazi, T. A., Chakravarti, R., Arya, M., Roy, D., Khan, A. N., Kundu, A., Gupta, R. K., Ghosh, A., & Bhattacharya, B. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-5878-8.ch002 · Cited by 1
Sorokina, M., & Steinbeck, C. (2019) · Preprints.org · doi:10.20944/preprints201912.0332.v1
“Khalifa SA, Elias N, Farag MA, Chen L, Saeed A, Hegazy M-EF, et al. Marine Natural Products: A Source of Novel Anticancer Drugs.”
BackgroundInfluentialRumengan, I. F. M., Modaso, R., Lintang, R., Rumampuk, N. D. C., & Posangi, J. (2020) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/517/1/012018 · Cited by 1
de França, P., Costa, J. H., Fill, T. P., Lancelotti, M., Ruiz, A. L. T. G., & Fantinatti‐Garboggini, F. (2020) · doi:10.21203/rs.3.rs-123886/v1
Review Artikel : Aktivitas Antikanker dari Spons Laut Genus Xestospongia
Fristiohady, P. S. I. A. P. A. (2021) · Jurnal Farmasi Medica/Pharmacy Medical Journal (PMJ) · doi:10.35799/pmj.4.1.2021.34519
Antiproliferative activity of marine brown algae-derived compounds: A review
Araújo, L. O., Silva, J. K. D. O., de Aguiar, B. A., Bezerra, J. L. D. S., Rodrigues, A. D. Q., & Paulini, F. (2021) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2021.11.1.0306
“The isolation or discovery of new molecules from these organisms can play a very important role as an alternative therapeutic agent in various diseases, mainly against cancer [15].”
ISOLATION AND SCREENING OF MARINE BACTERIA FOR THEIR POTENTIAL ANTIMICROBIAL PROPERTIES
Gunavathi, Y., Naik, B. K., & Kameswaran, S. (2021) · Journal of Emerging Technologies and Innovative Research
Tlili, S., Brahim, R. B., Sabatier, J., & Regaya, I. (2021) · Venoms and Toxins · doi:10.2174/2666121701666211124154216
Luna, A. M. G. (2009) · PubMed · doi:10.13130/2035-7680/405
Synthetic Approaches of Aplykurodinone‐1: A Minireview
Xun, W., & Xu, B. (2021) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.202100695
Mofeed, J., Deyab, M. A., & El-Bilawy, E. H. (2022) · Egyptian Journal of Botany · doi:10.21608/ejbo.2022.95865.1786
Suresh, J. I., & Lakshimi, V. I. (2022) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-9258-8.ch010
Potential Natural Product Derived Compounds for Lung Cancer Therapy
Chanvorachote, P., Hutamekalin, P., Chunhacha, P., & Zin, Z. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_16-1
Bioactive Natural Products from the Red Sea
Rateb, M. E., & Abdelmohsen, U. R. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-1587-8 · Cited by 3
Deng, N., Huang, H., Hu, Y., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1487922/v1
GRZYBY ENDOFITYCZNE W ROLI POTENCJALNYCH PRODUCENTÓW ZWIĄZKÓW PRZECIWNOWOTWOROWYCH
Getinger-Panek, A., & Bednarek, I. A. (2022) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.2478/am-2022.0006
Grzyby Endofityczne w Roli Potencjalnych Producentów Związków Przeciwnowotworowych
Getinger-Panek, A., & Bednarek, I. A. (2022) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.2478/am-2022-0006
Alsufyani, T. A., Al‐Otaibi, N., Alotaibi, N. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.20.513013
Biswas, I., Senthilathiban, D. P., Kuduvalli, S. S., Muralidharan, A. R., Akshaya, S., Raman, V., Prabhu, D., & Anitha, T. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.02.518791
Potential Natural Product–Derived Compounds for Lung Cancer Therapy
Chanvorachote, P., Hutamekalin, P., Chunhacha, P., & Zin, Z. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_16
Liu, H. S., & Wu, N. (2022) · Science of Advanced Materials · doi:10.1166/sam.2022.4277
Silver and gold nanoparticles: Promising candidates as antimicrobial nanomedicines
Vala, A. K., Andhariya, N., & Chudasama, B. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99454-5.00013-5
Xue, Y., Fu, Y., Zhao, F., Gui, G., Li, Y., Rivero-Hinojosa, S., Liu, G., Li, Y.-Q., Xia, S., Eberhart, C. G., et al. (2023) · doi:10.1158/1535-7163.22522281
Xue, Y., Fu, Y., Zhao, F., Gui, G., Li, Y., Rivero-Hinojosa, S., Liu, G., Li, Y., Xia, S., Eberhart, C. G., et al. (2023) · doi:10.1158/1535-7163.c.6543321
Hongwiangchan, N., & Chanvorachote, P. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.310
Moreira, E. A. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2022.tde-25082023-090154
The form and function of the animal cell
Browne, D. C., Young, R. E., & Francis, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18657-8.00028-1
Effect of Selected Fruit Wastes on Hematological Parameters in DEN-Induced Hepatic Carcinoma in Rats
Ashok Kumar, K., Vijayalakshmi, K., Suganthi, M., Wong, L. S., Abirami, G., Jayanthi, M., Karmegam, N., Prakash, B., & Balachandar, R. (2023) · Journal Of Advanced Zoology · doi:10.17762/jaz.v44i3.1729
“Plants are the major source of potential anti-cancer drugs, and they are currently used in 60% of anti-cancer drugs, including plants, marine organisms, and microorganisms (Khalifa et al., 2019).”
BackgroundIvanytsia, V., Гудзенко, Т. В., Gorshkova, O. H., Lisіutin, G. V., Штеніков, М. Д., Коротаєва, Н. В., Potapenko, K. S., Страшнова, І. В., & Ivanytsia, T. V. (2023) · The Ukrainian Biochemical Journal · doi:10.15407/ubj95.06.097 · Cited by 1
Vinothkumar, N., & Pugalendhi, P. (2024) · Journal of Applied Biology & Biotechnology · doi:10.7324/jabb.2024.160953
Zhang, J., Li, S., Lv, Q., Lin, J., Xiao, Y., Liang, J., Zhang, T., Zeng, L., Guo, P., & Ji, H. (2024) · The Natural Products Journal · doi:10.2174/0122103155275580231124052950
Multiple approaches to understanding the benthos
Lopez, J. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824112-7.00004-2 · Cited by 1
Automating Pharmacokinetic Predictions in Artemisia
Younan, C. (2023) · ScholarWorks (Boise State University) · doi:10.18122/td.2088.boisestate
Sekar, N., Padmanaban, D., Jayaprakash, V., et al. (2024) · Toxin Reviews · doi:10.1080/15569543.2024.2315415
Zaman, E., Aliabad, K. K., & Ostad‐Ali‐Askari, K. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4735304
Yang, X., Ren, W., peng, B., Li, S., Zheng, J., sun, K., Zhi, K., & Gao, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4229655/v1
Евгеньевна, Ф. С., Kushnerova, N. F., & Sprygin, V. G. (2024) · Журнал эволюционной биохимии и физиологии · doi:10.31857/s0044452924010067 · Cited by 1
Metadata
- Authors
- Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., Chang, F.-R., Iwasaki, A., Suenaga, K., Alajlani, M., Göransson, U., & El-Seedi, H. R.
- Affiliations
- Karolinska University Hospital (SE)
- University of Kalamoon (SY)
- Cairo University (EG)
- Fujian Agriculture and Forestry University (CN)
- Quaid-i-Azam University (PK)
- Johannes Gutenberg University Mainz (DE)
- Kuwait University (KW)
- Department of Chemistry, Faculty of Science, University of Kuwait, 13060 Safat, Kuwait
- University of Karachi (PK)
- Kaohsiung Medical University (TW)
- Keio University (JP)
- Uppsala University (SE)
- Jiangsu University (CN)
- Corresponding author
- El-Seedi, Hesham R.
- ORCID
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2019-08-23
- Volume
- 17
- Issue
- 9
- Pages
- 491
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC6780632
- OpenAlex
- W2969876208
- Semantic Scholar
- fc04613de468c55e3c00acaa04bbf85967f96088
- Cited by
- 555
- References
- 235
- Citations by year
- 2026: 32 · 2025: 73 · 2024: 100 · 2023: 88 · 2022: 109 · 2021: 98 · 2020: 49 · 2019: 4
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Uppsala University (Swedish Research links grant 2016-05885 (VR for the years 2017 - 2019))
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- marine natural products, anticancer agents, marine organisms, marine algae, marine bacteria, actinomycetes, marine fungi, marine sponges, soft coral, marine plants, apoptosis, cytotoxicity, cancer prevention, molecular mechanisms, bioactive metabolites, anticancer drug discovery
- MeSH terms
- Animals, Antineoplastic Agents, Biological Products, Clinical Trials as Topic, Disease Models, Animal, Humans, Neoplasms, Treatment Outcome, Aquatic Organisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.